Paediatric Research under the New eu Regulation on Clinical Trials: Old Issues New Challenges

European Journal of Health Law

Volumn 23, Issue 4, 2016, Pages 325-349

  Gennet, Éloïse ^a,b   Altavilla, Annagrazia ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

children; clinical trials; eu Regulation 536 2014; European law; paediatric research; research ethics

Indexed keywords

ADOPTION; CASE REPORT; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; HUMAN; PEDIATRICS; RESEARCH ETHICS;

EID: 84984780831     PISSN: 09290273     EISSN: 15718093     Source Type: Journal    
DOI: 10.1163/15718093-12341394     Document Type: Review

References (34)

1. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws. Regulations and administrative Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws. regulations and administr provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use [2001] OJ L 121/34.tive
2. European Medicines Agency (EMA), 'Successes of the Paediatric Regulation after 5 years' EMA/250577/2013 [2013]. 8 European Commission, 'Impact assessment report on the revision of the 'Clinical Trials Directive' 2001/20/EC. Volume II (Annexes)' SWD (2012) 200 final [2012], p. 9.
3. European Medicines Agency' EMA/INS/GCP/676319/2012 [2013], p. 9.
4. World Medical Association (WMA), 'Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects (as amended in 2013)' [1967], para. 28.
5. Minimal risk-that is, risk that is no more likely and not greater than that attached to routine medical or psychological examination'. Council for International Organizations of Medical Sciences (CIOMS), 'International Ethical Guidelines for Biomedical Research Involving Human Subjects' [2002], Guideline 10.
6. United Nations Educational, Scientific and Cultural Organization (UNESCO), 'Universal Declaration on Bioethics and Human Rights' [2006], Article 7.b). 25 Act on Research Ethics Review of Health Research Projects as updated on 9 October 2013, Section 19(3)3.
7. Code of Federal Regulations (CFR), Title 45, Section 46.404 Research not involving greater than minimal risk.
8. A.E. Westra et al., 'How best to define the concept of minimal risk', J Pediatr 159(3) (2011) 496-500, at 496.
9. A. Binik, 'On the minimal risk threshold in research with children', Am J Bioeth 9(14) (2014) 3-12, at 3.
10. see D. Wendler, 'Justice and nontherapeutic paediatric research', Am J Bioeth 9(14) (2014) 13-15
11. A.E. Westra and others, 'Drug development for children: how adequate is the current European ethical guidance?' Arch Dis Child 95(1) (2010) 3-6, at 3.
12. A. Rid, 'How should we regulate risk in biomedical research? An ethical analysis of recent policy proposals and initiatives', Health Policy 117(3) (2014) 409-420.
13. European Parliament, 'Report on the proposal for a regulation of the European Parliament and of the Council on clinical trials on medicinal products for human use, and repealing Directive 2011/20/EC (COM(2012)0368-C7-0194/2012-2012/0192(COD))' A7-0208/2013 [2013], Amendment 274, p. 136.
14. Mutualit A.I.M., et al., Joint Analysis 'New Proposal for a Regulation on Clinical Trials:-The protection of human subjects must be upheld-Citizens' right to information must be strengthened' [2013], p. 8.
15. H. Nys, 'New European rules regarding the approval of clinical trials, the role of ethics committees and the protection of subjects', Arch Immunol Ther Ex 60(6) (2012) 405-414.
16. A. Den Boer and I. Schipper, 'New EU regulation on clinical trials: the impact on ethics and safeguards for participants', Indian J Med Eth X(2) (2013) 106-109.
17. J. Heringa and J. Dute, 'The proposed EU-regulation on Clinical Trials on Medicinal Products; an unethical proposal?', Eur J Health L 20 (2013) 347-362.
18. Global Research in Paediatrics (GRiP), 'Children matter: important amendments in the draft Clinical Trials Regulation' [2013]
19. A.E. Westra and others, 'New EU clinical trials regulation needs a few tweaks before implementation' BMJ 348 (2014) 1-2.
20. C. Petrini, 'Regulation (EU) N?536/2014 on clinical trials on medicinal products for human use: An overview', Ann Ist Super Sanità 50(4) (2014) 317-321, at 320.
21. A. Altavilla et al., 'Impact of the new European paediatric regulatory framework on ethics committees: overview and perspectives', Acta Paediatr 101(1) (2012) 1-6, at 5.
22. European Commission, 'Assessment of the functioning of the 'Clinical Trials Directive' 2001/20/EC. Summary of the responses to the public consultation paper' SANCO/C/8/SF/dn D(2010) 380240 [2010], p. 6.
23. European Commission, 'Revision of the 'Clinical Trials Directive' 2001/20/EC. Summary of the replies to the public consultation on the 'Concept Paper" SANCO/D/3/PB/SF/ddg1.d.3(2011)816084 [2011], para. 38, p. 5.
24. It is coordinated by the German Reference Centre for Ethics in the Life Sciences (DRZE). Following already existing efforts, especially efforts within a previous project (EUREC), one of its primary objectives is to foster a sustainable infrastructure for European RECs. http://www.eurecnet.org/index.html.
25. Westra et al., 'New EU clinical trials regulation', supra note 72.
26. Centre of Genomics and Policy (CGP), Maternal Infant Child and Youth Research Network (MICYRN), 'Best Practices for Health Research Involving Children and Adolescents' [2012] p. 92.
27. European Commission Website, http://ec.europa.eu/justice/data-protection/review/index-en.htm.
28. A. Altavilla, 'Ethical standards for clinical trials conducted in third countries: The new strategy of the European Medicines Agency', Eur J Health L 18 (2011) 65-75.
29. G. Koski and S. L. Nightingale, 'Research involving human subjects in developing countries', NEJM 345 (2001) 136-138.
30. J.S. Hawkins and E.J. Emanuel, Exploitation and Developing Countries. The Ethics of Clinical Research (Princeton, NJ: Princeton University Press, 2008).
31. I. Schipper and F. Weyzig, 'Ethics for drug testing in low and middle income countries, considerations for European market authorisation', SOMO (2008) 77 .
32. The Oviedo Convention has been ratified by 29 countries to this date, Website of the Treaty Office from the Council of Europe, http://conventions.coe.int/Treaty/Commun/ChercheSig.asp?NT=164&CM=8&DF=23/02/2015&CL=ENG.
33. The Additional Protocol to the Oviedo Convention on Biomedical Research has been ratified by 9 countries to this date, Website of the Treaty Office from the Council of Europe, http://conventions.coe.int/Treaty/Com mun/ChercheSig.asp?NT=195&CM=8&DF=23/02/2015&CL=ENG.
34. ICH Steering Committee, 'Final Concept Paper E11(R1): Clinical Investigation of Medicinal Products in the Pediatric Population' [2014].